Loading...
Alvotech
ALVOW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.03
$-0.07(-3.33%)
Alvotech (ALVOW) Company Profile & Overview
Explore Alvotech’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Alvotech (ALVOW) Company Profile & Overview
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEORobert Wessman
Contact Information
Company Facts
1,012 Employees
IPO DateJun 16, 2022
CountryIS
Actively Trading